We are live on
!
Find out more
EP
Evelyn Partners Portfolio holdings
AUM
$46.9B
This Fund
S&P 500
This Quarter
Est. Return
-2.15%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$46.9B
AUM Growth
–
Cap. Flow
+$5.86B
Cap. Flow
% of AUM
12.5%
Top 10 Holdings %
Top 10 Hldgs %
93.6%
Holding
551
New
550
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$421M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$409M |
| 3 |
Amazon
AMZN
|
+$395M |
| 4 |
Microsoft
MSFT
|
+$378M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.62% |
| 2 | Technology | 2.91% |
| 3 | Financials | 2.09% |
| 4 | Communication Services | 1.32% |
| 5 | Consumer Discretionary | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRZ
326
Amrize Ltd
AMRZ
$20.6B
| $86.8K | ﹤0.01% |
+1,629
| New | +$88.2K |
|
327
Fox Class A
FOXA
$26.3B
| $85.5K | ﹤0.01% |
+1,640
| New | +$101K |
|
328
CBRE Group
CBRE
$37.9B
| $84.7K | ﹤0.01% |
+629
| New | +$86.7K |
|
329
PureCycle Technologies
PCT
$890M
| $84.6K | ﹤0.01% |
+10,432
| New | +$93.5K |
|
330
Copa Holdings
CPA
$5.43B
| $82.1K | ﹤0.01% |
+528
| New | +$68.7K |
|
331
Arm
ARM
$314B
| $81.6K | ﹤0.01% |
+230
| New | +$61.2K |
|
332
Moody's
MCO
$78.8B
| $81.1K | ﹤0.01% |
+179
| New | +$80.4K |
|
333
First Majestic Silver
AG
$8.91B
| $79.7K | ﹤0.01% |
+4,700
| New | +$93.1K |
|
334
NXP Semiconductors
NXPI
$59.6B
| $77.8K | ﹤0.01% |
+277
| New | +$76.3K |
|
335
Alibaba
BABA
$268B
| $77.1K | ﹤0.01% |
+803
| New | +$101K |
|
336
Omnicom Group
OMC
$20.3B
| $75.9K | ﹤0.01% |
+1,042
| New | +$78.4K |
|
337
Varonis Systems
VRNS
$5.41B
| $75.5K | ﹤0.01% |
+1,800
| New | +$52.8K |
|
338
Expeditors International
EXPD
$24.5B
| $72.5K | ﹤0.01% |
+445
| New | +$68.8K |
|
339
Crown Castle
CCI
$28.5B
| $71.9K | ﹤0.01% |
+950
| New | +$83.4K |
|
340
Canadian Natural Resources
CNQ
$97.2B
| $71.4K | ﹤0.01% |
+1,805
| New | +$82.1K |
|
341
Sun Life Financial
SLF
$44B
| $71.1K | ﹤0.01% |
+906
| New | +$65.2K |
|
342
Henry Schein
HSIC
$9.47B
| $71K | ﹤0.01% |
+850
| New | +$65K |
|
343
CRISPR Therapeutics
CRSP
$5.41B
| $70.9K | ﹤0.01% |
+1,300
| New | +$68.5K |
|
344
Imperial Oil
IMO
$58.9B
| $70.7K | ﹤0.01% |
+630
| New | +$78.9K |
|
345
The Kraft Heinz Company
KHC
$27.8B
| $68.7K | ﹤0.01% |
+2,908
| New | +$67.1K |
|
346
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$2.94B
| $67.8K | ﹤0.01% |
+1,554
| New | +$67.8K |
|
347
Royal Caribbean
RCL
$69.7B
| $66.7K | ﹤0.01% |
+210
| New | +$58.7K |
|
348
Insulet
PODD
$9.21B
| $64.7K | ﹤0.01% |
+425
| New | +$70.8K |
|
349
Occidental Petroleum
OXY
$54.9B
| $64.3K | ﹤0.01% |
+1,324
| New | +$75.2K |
|
350
ManpowerGroup
MAN
$2.63B
| $63.3K | ﹤0.01% |
+1,873
| New | +$57.3K |
|
Similar funds
VCMC
SCP
Evelyn Partners's Q2 2026 Portfolio in Review
Q2 2026 is the first quarter with a 13F filing on record for Evelyn Partners, which disclosed 551 positions worth $46.9B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is AstraZeneca: 2,237,205 shares worth $41.5B.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, followed by Technology and Financials.
- Evelyn Partners's largest Q2 2026 buy was AstraZeneca: 2,237,205 shares worth $41.5B.
- Evelyn Partners's ten largest holdings make up 94% of its $46.9B portfolio in Q2 2026.
- Evelyn Partners disclosed 551 positions in Q2 2026, its first 13F filing on record.
Based on Evelyn Partners's 13F filing for Q2 2026, filed 7 Aug 2026.